Parker has over 9 years of experience working with pre-commercial biotechs through the largest life sciences firms, supporting a broad range of commercialization issues. Parker’s work has spanned across strategy, implementation and operations, leveraging both primary and secondary data to maximize insights and impact. His therapeutic areas of focus include oncology, rare disease and diabetes, among others.

Parker has a M.S. in Technology Management and B.A. in Economics from the University of Illinois Urbana-Champaign. Outside the office Parker is a passionate road cyclist and Crossfitter.